News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Expert panel recommends FDA approve Takeda bowel disease drug

Started by riky, December 10, 2013, 09:00:22 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Expert panel recommends FDA approve Takeda bowel disease drug

<p><a href="http://news.yahoo.com/expert-panel-recommends-fda-approve-takeda-bowel-disease-225014322--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/1AWDIMbL_mFB9DFQzS5FpQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-12-09T225014Z_1_CBRE9B81RFX00_RTROPTP_2_SWITZERLAND.JPG" width="130" height="86" alt="The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg" align="left" title="The logo of Japanese Takeda Pharmaceutical Co is seen at an office building in Glattbrugg" border="0" /></a>(Reuters) - An advisory panel of medical experts on Monday voted to recommend that U.S. health regulators approve an experimental drug for ulcerative colitis and Crohn's disease developed by Takeda Pharmaceutical Co. There were specific safety and efficacy questions for each of the two conditions put before the panel. It ultimately found by wide margins that the benefits outweigh the risks of the biotech drug, vedolizumab, and advised the Food and Drug Administration to approve it for ulcerative colitis and Crohn's disease in patients who have not been helped by prior therapies. The FDA typically follows the recommendations of its expert advisory panels but is not obligated to do so.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login